Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6176)
All Articles published online
|
Publishing Process of This Article
|
Jan 15, 2024 (publication date) through Mar 2, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Han LL, Wang SH, Yao MY, Zhou H. Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease. World J Diabetes 2024; 15(1): 92-104 [PMID: 38313849 DOI: 10.4239/wjd.v15.i1.92] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Han LL, Wang SH, Yao MY, Zhou H. Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease. World J Diabetes 2024; 15(1): 92-104 [PMID: 38313849 DOI: 10.4239/wjd.v15.i1.92] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v15/i1/92.htm |
| Number | Citing Articles |
| 1 |
Jiangyuan Jin, Mianzhi Zhang. Research progress on the role of extracellular vesicles in the pathogenesis of diabetic kidney disease. Renal Failure 2024; 46(1) doi: 10.1080/0886022X.2024.2352629
|
| 2 |
Yixuan Fang, Shiyi Sun, Jing Wu, Guanjian Liu, Qinqin Wu, Xingwu Ran. Alterations in the Levels of Urinary Exosomal MicroRNA-183-5p and MicroRNA-125a-5p in Individuals with Type 2 Diabetes Mellitus. Biomedicines 2024; 12(11): 2608 doi: 10.3390/biomedicines12112608
|
| 3 |
Haiying Zhang, Yubo Jiang, Jun Song, Shaoqing Wang, Jianhong Lu, Fuxin Wei, Xiu Li. Urinary exosomes exacerbate diabetic kidney disease by promoting NLRP3 inflammasome activation via the microRNA-516b-5p/SIRT3/AMPK pathway. American Journal of Physiology-Endocrinology and Metabolism 2025; 328(6): E911 doi: 10.1152/ajpendo.00527.2024
|
| 4 |
Anupriya Baranwal, Vipul Bansal, Ravi Shukla. Emerging Biomarkers and Nanobiosensing Strategies in Diabetes. Biosensors 2025; 15(10): 639 doi: 10.3390/bios15100639
|
| 5 |
Li Xu, Xiuli Guo, Wen Gan, Linhong Yao, Jianing Wang, Qi Li, Qiuling Fan. Diagnostic value of the correlation between urinary MDM2 and podocyte mitotic catastrophe in diabetic kidney disease. Diabetology & Metabolic Syndrome 2025; 17(1) doi: 10.1186/s13098-025-01856-9
|
| 6 |
Shaimaa I. Barr, Eman M. Abd El-Azeem, Sahar S. Bessa, Tarek M. Mohamed. Role of exosomes in pathogenesis, diagnosis, and treatment of diabetic nephropathy. BMC Nephrology 2025; 26(1) doi: 10.1186/s12882-025-04120-4
|
| 7 |
Yang Yu, Yunjie Shan, Anjie Ding, Hui Qian. Extracellular vesicles in diabetic kidney disease: Emerging mechanisms, therapeutic implications, and biomarker prospects. Biochemical Pharmacology 2026; 244: 117605 doi: 10.1016/j.bcp.2025.117605
|
| 8 |
Shiyuan Huang, Fang Yan, Yi Qiu, Tao Liu, Wenjin Zhang, Yige Yang, Rao Zhong, Yang Yang, Xi Peng. Exosomes in inflammation and cancer: from bench to bedside applications. Molecular Biomedicine 2025; 6(1) doi: 10.1186/s43556-025-00280-9
|
| 9 |
Domenico Santoro, Luigi Peritore, Flavia Sudano, Simona Di Piazza, Maria Federica Ricca, Michela Calderone, Felicia Cuzzola, Giuseppe Spadaro, Lorenzo Lo Cicero, Rossella Messina, Luca Soraci, Guido Gembillo. Urinary biomarkers of diabetic kidney disease. World Journal of Diabetes 2026; 17(1): 110502 doi: 10.4239/wjd.v17.i1.110502
|
| 10 |
Asif Mondal, Sucharita Banerjee, Somnath Naskar, Chiranjit Bose, Chinmay Saha, Subhasish Pramanik, Bidisha Mukherjee, Piyali Jati, Pranab Kumar Sahana, Rayaz A. Malik, Satinath Mukhopadhyay. miR‐27a‐3p Upregulation and Netrin‐1 Deficiency Drive Inflammatory Responses and Nerve Degeneration in Patients With Diabetes. European Journal of Neurology 2025; 32(12) doi: 10.1111/ene.70449
|
| 11 |
Md. Sohanur Rahman, Suvankar Ghorai, Kingshuk Panda, Maria J. Santiago, Saurabh Aggarwal, Ting Wang, Irfan Rahman, Srinivasan Chinnapaiyan, Hoshang J. Unwalla. Dr. Jekyll or Mr. Hyde: The multifaceted roles of miR-145-5p in human health and disease. Non-coding RNA Research 2025; 11: 22 doi: 10.1016/j.ncrna.2024.11.001
|
| 12 |
Jiale Li, Jun Peng, Haijun Guo, Wei Zheng, Rui Chen, Changfeng Miao, Jiachong Wang, Zigui Chen, Chunhai Tang. Exosome-based liquid biopsy for rare and complex diseases. International Journal of Surgery 2026; 112(2): 4672 doi: 10.1097/JS9.0000000000003951
|
| 13 |
Yimo Huang, Wende Ma, Cen Guo, Xiaoling Su. Mechanism of action and potential therapeutic targets of TGF-β-related signaling pathway and its downstream miRNA expression in pulmonary arterial hypertension. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1596767
|
| 14 |
Miao Hu, Yi Deng, Zhen Weng, Yujie Bai, Jiayan Zhang, Jianzhong Li, Lei Shen, Xiahong Shen, Ling Zhou. Expression and clinical significance of platelet-derived miR-145-5p and miR-6805-3p in diabetic kidney disease patients. Frontiers in Medicine 2026; 12 doi: 10.3389/fmed.2025.1529759
|
| 15 |
Masoomeh Hamdi, Alireza Rahimizadeh, Mojdeh Ahmadi, Maryam Davoodi, Sahar Sadegh-Nejadi, Amirreza Ghafourian, Hamid Choobineh, Reza Afrisham. A systematic review of urinary extracellular vesicle-derived non-coding RNAs in diabetic nephropathy: expression profiles, clinical correlations, and diagnostic performance. Molecular Biology Reports 2026; 53(1) doi: 10.1007/s11033-026-11523-5
|
| 16 |
Huanhuan Cao, Zixi Li, Jiajia Ye, Yi Lv, Chun Zhang, Tao Liang, Yumei Wang. Emerging roles of exosomes in the diagnosis and treatment of kidney diseases. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1525314
|
| 17 |
Bhavana Bagdaram Choudhary, Bhupendra Puri, Anil Bhanudas Gaikwad. Novel molecular biomarkers in kidney diseases: bridging the gap between early detection and clinical implementation. Journal of Pharmacy and Pharmacology 2026; 78(2) doi: 10.1093/jpp/rgaf096
|